Different aspects of peritoneal damage: Fibrosis and sclerosis

Contributions to Nephrology

Volumn 163, Issue , 2009, Pages 45-53

  Garosi, Guido ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; CHRONIC DISEASE; DISEASE MODEL; EPITHELIUM; FIBROSIS; HUMAN; KIDNEY DISEASE; PATHOLOGY; PERITONEAL DIALYSIS; PERITONEUM; RABBIT; RAT; SCLEROSIS;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EPITHELIUM; FIBROSIS; HUMANS; KIDNEY DISEASES; PERITONEAL DIALYSIS; PERITONEUM; RABBITS; RATS; SCLEROSIS;

EID: 67651204589     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000223779     Document Type: Article

References (36)

1. Garosi G, Di Paolo N, Sacchi G, Gaggiotti E: Sclerosing peritonitis: a nosological entity. Perit Dial Int 2005;25(S3):S110-S112
2. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H: Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol 2008;3:720-728
3. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, MacKenzie RK, Williams GT: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470-479
4. Garosi G, Di Paolo N: Peritoneal sclerosis: one or two nosological entities? Semin Dial 2000; 13:297-308
5. Gotloib L, Wajsbrot V, Shostak A: A short review of experimental peritoneal sclerosis: from mice to men. Int J Artif Organs 2005;28:97-104
6. Garosi G, Gaggiotti E, Monaci G, Brardi S, Di Paolo N: Biocompatibility of a peritoneal dialysis solution with amino acids: histological study in the rabbit. Perit Dial Int 1998;18:610-619
7. De Vriese AS, Tilton RG, Mortier S, Lameire NH: Myofi broblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fi brosis in uremia. Nephrol Dial Transplant 2006;21:2549-2555
8. Kolesnyk I, Dekker FW, Noordzij M, le Cessie S, Struijk DG, Krediet RT: Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients. Perit Dial Int 2007;27:446-453
9. Sampimon DE, Coester AM, Struijk DG, Krediet RT: Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis. Adv Perit Dial 2007;23:107-111
10. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG: Encapsulating peritoneal sclerosis: defi nition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis ad Hoc Committee on Ultrafi ltration Management in Peritoneal Dialysis. Perit Dial Int 2000;20(S4):S43-S55
11. Fieren MWJA, Betjes MGH, Korte MR, Boer WH: Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 2007;27:619-624
12. Di Paolo N, Sacchi G, Garosi G, Sansoni E, Bargagli L, Ponzo P, Tanganelli P, Gaggiotti E: Omental milky spots and peritoneal dialysis: review and personal experience. Perit Dial Int 2005;25:48-57
13. Garosi G, Di Paolo N: Infl ammation and gross vascular alterations are characteristic histological features of sclerosing peritonitis. Perit Dial Int 2001;21:417-418
14. Honda K, Nitta K, Horita S, Tsukada M, Itabashi M, Nihei H, Takashi A, Oda H: Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003;19:169-175
15. Nakayama M, Maruyama Y, Numata M: Encapsulating peritoneal sclerosis is a separate entity: con. Perit Dial Int 2005;25(S3):S107-S109
16. Sherif AM, Yoshida H, Maruyama Y, Yamamoto H, Yokoyama K, Hosoya T, Kawakami M, Nakayama M: Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis. Ther Apher Dial 2008;12:33-41
17. Hardie EM, Rottman JB, Levy JK: Sclerosing encapsulating peritonitis in four dogs and a cat. Vet Surg 1994;23:107-114
18. Komatsu H, Uchiyama K, Tsuchida M, Isoyama N, Matsumura M, Hara T, Fukuda M, Kanaoka Y, Naito K: Development of a peritoneal sclerosis rat model using a continuous-infusion pump. Perit Dial Int 2008;28:641-647
19. Owtschinnikow PJ: Peritonitis chronica fi brosa incapsulata. Arch Klin Chir 1907;83:623-634
20. Narayanan R, Bhargava BN, Kabra SG, Sangal BC: Idiopathic sclerosing encapsulating peritonitis. Lancet 1989;ii:127-129
21. Dehn TC, Lucas MG, Wood RF: Idiopathic sclerosing peritonitis. Postgrad Med J 1985;61:841- 842
22. Comings DE, Skubi KD, Van Eyes J, Motulsky AG: Familial multifocal fi brosclerosis. Ann Intern Med 1967;66:884-892
23. Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME: Encapsulating peritoneal sclerosis: clinical signifi cance and implications. Nephron Clin Pract 2009;111:c149-c154
24. Summers AM, Brenchley PEC: An international encapsulating peritoneal sclerosis registry and DNA bank: why we need one now. Perit Dial Int 2006;26:559-563
25. Topley N: Encapsulating peritoneal sclerosis: time to act. Perit Dial Int 2006;26:564-565
26. Duman S, Ozbek SS, Gunay ES, Bozkurt D, Asci G, Sipahi H, Kircelli F, Ertilav M, Ozkahya M, Ok E: What does peritoneal thickness in peritoneal dialysis patients tell us? Adv Perit Dial 2007;23:28-33
27. Tarzi RM, Lim A, Moser S, Ahmad S, George A, Balasubramaniam G, Clutterbuck EJ, Gedroyc W, Brown EA: Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis. Clin J Am Soc Nephrol 2008;3:1702-1710
28. Tarzi RM, Frank JW, Ahmad S, Levy JB, Brown EA: Fluorodeoxyglucose positron emission tomography detects the infl ammatory phase of sclerosing peritonitis. Perit Dial Int 2006;26:224-230
29. Kawanishi H, Ide K, Yamashita M, Shimomura M, Moriishi M, Tsuchiya S, Dohi K: Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis. Adv Perit Dial 2008;24:51-55
30. Rajani R, Smyth J, Abbs I, Goldsmith JA: Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis. Nephrol Dial Transplant 2002;17:2278-2280
31. Ricciatti AM, Goteri G, D'Arezzo M, Sagripanti S, Bibiano L, Petroselli F, Fabris G, Frascà GM: Peritonite sclerosante trattata con successo con associazione di steroidi, everolimus e tamoxifene (abstract). Atti XIV Convegno Gruppo di Studio di Dialisi Peritoneale, Modena, Italy, 7-9 febbraio 2008, p 20
32. Lafrance JP, Létourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, Michette V: Successful treatment of encapsulating peritoneal sclerosis with immunosoppressive therapy. Am J Kidney Dis 2008;51:e7-e10
33. Wong CF: Clinical experience with tamoxifen in encapsulating peritoneal sclerosis. Perit Dial Int 2006;26:183-184.
34. Pusateri R, Ross R, Marshall R, Meredith JH, Hamilton RW: Sclerosing encapsulating peritonitis: report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature. Am J Kidney Dis 1986;8:56-60
35. Mazure R, Marty FP, Niveloni S, Pedreira S, Vazquez H, Smecuol E, Kogan Z, Boerr L, Maurino E, Bai JC: Successful treatment of retractile mesenteritis with oral progesterone. Gastroenterology 1998;114:1313-1317
36. Struijk DG, van der Reijden HJ, Krediet RT, Koomen GC, Arisz L: Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis. Nephron 1989;51:577-578